Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial

Abstract Background Knee osteoarthritis (KOA) is one of the most common musculoskeletal disorders. Acupotomy may be effective for KOA, but the evidence is limited. This trial aims to determine the effectiveness and safety of acupotomy for KOA. Methods/design This is a parallel-group, assessor-blinde...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shu-Ming Li, Tian-Li Li, Ren Guo, Ping Chen, Wei-Shuai Du, Si-Bo Kang, Ming-Zhe Yan, Wu-Zhong Cheng
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/f37219bddb714251b13d14cce41bf326
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f37219bddb714251b13d14cce41bf326
record_format dspace
spelling oai:doaj.org-article:f37219bddb714251b13d14cce41bf3262021-11-21T12:31:26ZEffectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial10.1186/s13063-021-05786-51745-6215https://doaj.org/article/f37219bddb714251b13d14cce41bf3262021-11-01T00:00:00Zhttps://doi.org/10.1186/s13063-021-05786-5https://doaj.org/toc/1745-6215Abstract Background Knee osteoarthritis (KOA) is one of the most common musculoskeletal disorders. Acupotomy may be effective for KOA, but the evidence is limited. This trial aims to determine the effectiveness and safety of acupotomy for KOA. Methods/design This is a parallel-group, assessor-blinded randomized controlled trial. Two hundred patients with KOA will be recruited and randomly assigned to two groups (group A or group D) in a 1:1 ratio. Patients in group A will receive acupotomy and topical diclofenac diethylamine for 4 weeks, while patients in group D will receive topical diclofenac diethylamine alone for 4 weeks. The primary outcome will be the response rate—the proportion of patients who achieve the minimal clinically important improvement in pain and function at week 4 compared with baseline. Secondary outcomes will include pain, function, quality of life, the use of rescue medicine (loxoprofen sodium), and adverse events at weeks 4, 8, and 24 after randomization. Besides, joint fluid and serum will be collected to assess the level of inflammatory cytokines, like TNF-α, IL-1β, and MMP-3. Discussion This study will contribute to a better understanding of the effectiveness and safety of acupotomy in combination with topical nonsteroidal anti-inflammatory drugs. If the hypothesis is confirmed, acupotomy may be recommended as adjunctive therapy for patients with KOA. Results of the study will be of great importance for the guidelines of clinical therapy. Trial registration Chinese Clinical Trial Registry ChiCTR2100043005 Registered on 4 February 2021.Shu-Ming LiTian-Li LiRen GuoPing ChenWei-Shuai DuSi-Bo KangMing-Zhe YanWu-Zhong ChengBMCarticleKnee osteoarthritisAcupotomyNSAIDsRandomized controlled trialMedicine (General)R5-920ENTrials, Vol 22, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Knee osteoarthritis
Acupotomy
NSAIDs
Randomized controlled trial
Medicine (General)
R5-920
spellingShingle Knee osteoarthritis
Acupotomy
NSAIDs
Randomized controlled trial
Medicine (General)
R5-920
Shu-Ming Li
Tian-Li Li
Ren Guo
Ping Chen
Wei-Shuai Du
Si-Bo Kang
Ming-Zhe Yan
Wu-Zhong Cheng
Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
description Abstract Background Knee osteoarthritis (KOA) is one of the most common musculoskeletal disorders. Acupotomy may be effective for KOA, but the evidence is limited. This trial aims to determine the effectiveness and safety of acupotomy for KOA. Methods/design This is a parallel-group, assessor-blinded randomized controlled trial. Two hundred patients with KOA will be recruited and randomly assigned to two groups (group A or group D) in a 1:1 ratio. Patients in group A will receive acupotomy and topical diclofenac diethylamine for 4 weeks, while patients in group D will receive topical diclofenac diethylamine alone for 4 weeks. The primary outcome will be the response rate—the proportion of patients who achieve the minimal clinically important improvement in pain and function at week 4 compared with baseline. Secondary outcomes will include pain, function, quality of life, the use of rescue medicine (loxoprofen sodium), and adverse events at weeks 4, 8, and 24 after randomization. Besides, joint fluid and serum will be collected to assess the level of inflammatory cytokines, like TNF-α, IL-1β, and MMP-3. Discussion This study will contribute to a better understanding of the effectiveness and safety of acupotomy in combination with topical nonsteroidal anti-inflammatory drugs. If the hypothesis is confirmed, acupotomy may be recommended as adjunctive therapy for patients with KOA. Results of the study will be of great importance for the guidelines of clinical therapy. Trial registration Chinese Clinical Trial Registry ChiCTR2100043005 Registered on 4 February 2021.
format article
author Shu-Ming Li
Tian-Li Li
Ren Guo
Ping Chen
Wei-Shuai Du
Si-Bo Kang
Ming-Zhe Yan
Wu-Zhong Cheng
author_facet Shu-Ming Li
Tian-Li Li
Ren Guo
Ping Chen
Wei-Shuai Du
Si-Bo Kang
Ming-Zhe Yan
Wu-Zhong Cheng
author_sort Shu-Ming Li
title Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
title_short Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
title_full Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
title_fullStr Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
title_full_unstemmed Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
title_sort effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial
publisher BMC
publishDate 2021
url https://doaj.org/article/f37219bddb714251b13d14cce41bf326
work_keys_str_mv AT shumingli effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT tianlili effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT renguo effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT pingchen effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT weishuaidu effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT sibokang effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT mingzheyan effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
AT wuzhongcheng effectivenessandsafetyofacupotomyforkneeosteoarthritisstudyprotocolforarandomizedcontrolledtrial
_version_ 1718418981397725184